BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial

SABRE (Copper-64 SAR-Bombesin in Biochemical Recurrence of prostate cancer) is a Phase II Positron Emission Tomography (PET) imaging tr...

July 25, 2023 | News

RenovoRx and Imugene Join Forces for Oncolytic Virus Therapy Using TAMP Platform

Collaboration will explore trans-arterial delivery of Imugene's CF33 oncolytic virus utilizing RenovoRx's TAMP therapy platform TAMP enables localized, ...

July 25, 2023 | News

Menarini Silicon Biosystems Launches New CELLSEARCH® CTC Test for Small Cell Lung Cancer with DLL3 Biomarker

Menarini Silicon Biosystems (MSB), a pioneer in liquid biopsy and single cell technologies, announced today the availability of its new CELLSEARCH CTC...

July 14, 2023 | News

NK:IO Secures £1.6M Innovate UK Grant for Pioneering Cancer Therapy

Grant award of £1.6M supports program of development work with Cell and Gene Therapy Catapult NK:IO’s platform, based on pionee...

July 11, 2023 | News

GeneQuantum Healthcare and Aimed Bio collaborate to develop 5 innovative ADC drugs

Since April of last year, GeneQuantum and Aimed Bio have been collaborating on the joint development of a FGFR3-targeting ADC named GQ1011/AMB302. The prog...

July 07, 2023 | News

Jacobio Receives CDE Approval for Glecirasib's Pancreatic Cancer Pivotal Study in China

The pivotal clinical trial approved in China will evaluate the efficacy and safety of Glecirasib as a single agent for the second line treatment ...

July 05, 2023 | News

Oncodesign Services announce access to ImaginAb’s CD8 ImmunoPET™ technology

By using this cutting-edge imaging technology in preclinical studies, Oncodesign Services’ team hopes to gain insights of the predictive effectivenes...

June 29, 2023 | News

Prenetics and Prof. Dennis Lo Launch US$200m Joint Venture "Insighta" for Multi-Cancer Early Detection

- Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo. - Insighta is powered by technology developed by the Centre for Novostics w...

June 26, 2023 | News

NCCN Unveils Thyroid Cancer Care Roadmap for Low- and Middle-Income Countries on Global Stage

The National Comprehensive Cancer Network® (NCCN®) is introducing a new global resource to improve thyroid cancer care in low- and middle-inco...

June 15, 2023 | News

Biostar Pharma Enrolls First Patient for Phase 1 Study of UTD2, World's First Oral Epothilone Anti-Cancer Drug

This study will be conducted at multiple clinical research centers including Sarah Cannon Research Institute (Florida Cancer Specialists & Research Ins...

June 13, 2023 | News

HKSH Medical Group and UCLA Health signed a Development Agreement

HKSH Medical Group (HKSH) and UCLA Health have signed a Development Agreement to strengthen their partnership in knowledge transfer in cancer management. T...

June 13, 2023 | News

Dizal Highlights Oncology Pipeline Strength at 2023 ASCO, Leading China's Biotech Innovation

Two highly anticipated oral presentations captured attention: first pivotal study of sunvozertinib (WU-KONG6) and multinational pivotal study of golidoci...

June 08, 2023 | News

Agilent BioTek Celebrates a Decade of Cell Imaging and Microscopy Innovation

Agilent Technologies Inc. (NYSE: A) announces the 10th anniversary of the Agilent BioTek Cytation 3 cell imaging multimode reader and the Agilen...

June 01, 2023 | News

Lunit and the JNCCHE Partner in AI Pathology to Advance Precision Oncology

Lunit (KRX:328130.KQ), a global provider of AI-powered cancer diagnostic solutions, today announced collaboration with the National Cancer Center...

May 31, 2023 | News

Stay Connected